These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14614012)

  • 41. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
    van de Geijn GJ; Gits J; Touw IP
    J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.
    Sutherland KD; Lindeman GJ; Choong DY; Wittlin S; Brentzell L; Phillips W; Campbell IG; Visvader JE
    Oncogene; 2004 Oct; 23(46):7726-33. PubMed ID: 15361843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia.
    Johan MF; Bowen DT; Frew ME; Goodeve AC; Reilly JT
    Br J Haematol; 2005 Apr; 129(1):60-5. PubMed ID: 15801956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
    Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
    Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
    Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
    Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
    Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
    Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
    Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA.
    Vlotides G; Sörensen AS; Kopp F; Zitzmann K; Cengic N; Brand S; Zachoval R; Auernhammer CJ
    Biochem Biophys Res Commun; 2004 Jul; 320(3):1007-14. PubMed ID: 15240148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of Wnt inhibitory factor-1 expression in hepatocellular carcinoma that is independent of gene methylation.
    Huang L; Li MX; Wang L; Li BK; Chen GH; He LR; Xu L; Yuan YF
    Tumour Biol; 2011 Feb; 32(1):233-40. PubMed ID: 21052890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppressor of cytokine signaling 1, a newly proposed tumor suppressor gene associated with hepatocellular carcinoma.
    Ohkawa K
    J Gastroenterol; 2004 Jun; 39(6):598-600. PubMed ID: 15235884
    [No Abstract]   [Full Text] [Related]  

  • 52. CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma.
    Zhang C; Guo X; Jiang G; Zhang L; Yang Y; Shen F; Wu M; Wei L
    Int J Cancer; 2008 Sep; 123(5):998-1004. PubMed ID: 18546260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA binding protein A expression and methylation status in hepatocellular carcinoma and the adjacent tissue.
    Yasen M; Obulhasim G; Kajino K; Mogushi K; Mizushima H; Tanaka S; Tanaka H; Hino O; Arii S
    Int J Oncol; 2012 Mar; 40(3):789-97. PubMed ID: 22159460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer.
    He B; You L; Uematsu K; Zang K; Xu Z; Lee AY; Costello JF; McCormick F; Jablons DM
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14133-8. PubMed ID: 14617776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects of DNMT1 Gene Silencing on Methylation of SOCS-1 Gene in Myeloma Cells].
    Wang Z; Niu XQ; Zhou WW; Lu QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):713-7. PubMed ID: 26117023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
    Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J
    Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection.
    Zhang F; Fan YC; Mu NN; Zhao J; Sun FK; Zhao ZH; Gao S; Wang K
    J Viral Hepat; 2014 Apr; 21(4):241-50. PubMed ID: 24597692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppressor of cytokine signaling (SOCS) genes are silenced by DNA hypermethylation and histone deacetylation and regulate response to radiotherapy in cervical cancer cells.
    Kim MH; Kim MS; Kim W; Kang MA; Cacalano NA; Kang SB; Shin YJ; Jeong JH
    PLoS One; 2015; 10(4):e0123133. PubMed ID: 25849377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
    Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
    Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
    Li B; Liu W; Wang L; Li M; Wang J; Huang L; Huang P; Yuan Y
    Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.